Major commercial expansion of its U.S. strategy through logistics and distribution agreement
NEW YORK, NY – June 10th, 2025 – Gelteq Limited (“Gelteq” or the “Company”), a clinical and science-based company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care, sports and other products, today announced a major expansion of its U.S. commercial strategy through an exclusive logistics and distribution agreement with Healthy Extracts Inc. (“Healthy Extracts”)(OTCQB: HYEX), a publicly traded company focused on plant-based health supplements.
The agreement names Healthy Extracts as Gelteq’s exclusive North American storage, shipping, and fulfillment partner, further building on the earlier purchase order placed by Healthy Extracts for Gelteq products. By partnering with Healthy Extracts, Gelteq expects to rapidly scale distribution of its proprietary delivery technologies across the United States and Canada while significantly reducing costs and boosting revenue potential.
“This fulfillment partnership with Healthy Extracts creates a powerful springboard for our North American expansion,” said Nathan Givoni, CEO of Gelteq. “We believe Healthy Extracts’ infrastructure and capabilities will allow us to execute with greater speed, precision, and efficiency – getting our products into more hands, faster.”
Under the new agreement, Healthy Extracts will manage all product receiving, secure warehousing, inventory, and order fulfillment from its Henderson, Nevada facility, which is optimized for high-volume distribution.
“Duke” Pitts, President of Healthy Extracts, commented: “By serving as Gelteq’s operational backbone in the U.S. and Canada, we expect to enhance margin efficiencies, drive faster delivery, and open new doors for long-term revenue growth. We believe this is a scalable, profitable model for both companies and our shareholders.”
Highlights of the Agreement:
- Exclusive Fulfillment & Logistics Partnership – Healthy Extracts will manage storage and all outbound shipping for Gelteq products across North America.
- Integrated Operational Systems – Real-time inventory management and centralized logistics expected improve transparency and efficiency.
- Accelerated Margin Expansion – The collaboration is expected to reduce fulfillment costs and unlock high-margin revenue opportunities for both Gelteq and Healthy Extracts.
The initial products to be received under this new agreement are on track for market distribution by Q3 2025. With the addition of full-service logistics, both Gelteq and Healthy Extracts are now vertically aligned to execute their growth plans, innovate new formulations, and enter broader consumer segments.
The agreement underscores both companies’ commitment to operational excellence and long-term value creation in the health and wellness market.
About Gelteq Ltd.
Headquartered in Melbourne, Australia, Gelteq (NASDAQ: GELS) is a clinical and science-based company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care, sports and other products. Gelteq advances and commercializes its delivery solutions within five core verticals: pharmaceuticals, over-the-counter medications, nutraceuticals, animal medications, and sports nutrition.
The Company’s unique formulation directly addresses the issues associated with traditional drug delivery methods such as difficulty swallowing, taste of unpalatable ingredients, and dosage control. For more information, visit www.gelteq.com and our SportsGel brand website www.sportsgel.com.
About Healthy Extracts Inc. (OTCQB: HYEX)
Healthy Extracts Inc. develops and markets proprietary, science-based supplements targeting brain, heart, and gut health. Its brand platform leverages clinically tested formulas and exclusive partnerships to deliver wellness solutions that drive measurable consumer and shareholder value.
Gelteq Contact:
Investor Relations
Matt Kreps, Darrow Associates IR
+1-214-597-8200
Forward-Looking Statements
Certain statements in this press release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as “anticipate,” “believe,” “contemplate,” “could,” “estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “suggest,” “target,” “aim,” “should,” “will,” “would,” or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on Gelteq’s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict, including risks related to the timing and fulfilment of current and future orders relating to Gelteq’s products, the success of new programs, the ability to implement a new strategic plan and the success of a new strategic plan. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. For a further discussion of risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of Gelteq in general, see the risk factors in its Annual Report on 20-F filed on November 15, 2024. All such forward-looking statements speak only as of the date they are made, and Gelteq undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise.